| APC | Activated Protein C |
| AUC | Area Under the Curve |
| CCS | Childhood Cancer Survivors |
| cfDNA | Cell-Free DNA |
| CMR | Cardiac Magnetic Resonance |
| CORE | Cardio-Oncology Rehabilitation and Exercise |
| CRF | Cardiorespiratory Fitness |
| CRP | C-Reactive Protein |
| CS | Cancer Survivors (general) |
| CVD | Cardiovascular Disease |
| CX3CL1 | Fractalkine |
| DNase I | Deoxyribonuclease I |
| DNA | Deoxyribonucleic Acid |
| ESC/ICOS | European Society of Cardiology/International Cardio-Oncology Society |
| FGF21 | Fibroblast Growth Factor 21 |
| HMGB1 | High Mobility Group Box 1 |
| HFA | Heart Failure Association |
| ICOS-CORE | International Cardio-Oncology Society—Cardio-Oncology Rehabilitation and Exercise |
| IL | Interleukin |
| IL-6 | Interleukin-6 |
| IL-8 | Interleukin-8 |
| IL-10 | Interleukin-10 |
| IL-1ra | Interleukin-1 receptor antagonist |
| IR | Ischemia–Reperfusion |
| LV | Left Ventricle/Left Ventricular |
| MAPK | Mitogen-Activated Protein Kinase |
| MPO-DNA | Myeloperoxidase–DNA complex |
| NCDs | Non-Communicable Diseases |
| NETs | Neutrophil Extracellular Traps |
| NETosis | Neutrophil Extracellular Trap Formation |
| PA | Physical Activity |
| PAD4 | protein-arginine deiminase 4 |
| SASP | Senescence-Associated Secretory Phenotype |
| TF | Tissue Factor |
| TFPI | Tissue Factor Pathway Inhibitor |
| TLR4 | Toll-Like Receptor 4 |
| TNF-α | Tumor Necrosis Factor-alpha |
| TM | Thrombomodulin |
| TTE | Transthoracic Echocardiography |
| VEGF | Vascular Endothelial Growth Factor |
| VO2 peak | Peak Oxygen Consumption |
| vWF | von Willebrand Factor |
| YAP | Yes-Associated Protein |